Skip to main content
. 2019 Nov 22;35(1):227–234. doi: 10.1080/14756366.2019.1693555

Table 3.

Pharmacokinetic profiles of compounds 17a, 17b in ICR mice.a

Compounds 17a 17b
AUC 0∼24 (ng·h/mL) 861.2 233.7
Cmax (ng/mL) 479.3 74.8
T1/2 (h) 1.2 5.2
Bioavailability (%) 19 0.7
a

All parameters were determined after oral administration (10 mg/kg, n = 3) and intravenous (iv) injection (3 mg/kg, n = 2) in ICR mice; both compounds were dissolved in a vehicle solution of DMSO/Tween80/saline (1:6:23) for iv., and 0.5% methylcellulose/0.5% Tween80 in distilled water for oral administration. Data represent mean values.